Fig 1.
Screening, enrollment, and patients eligible for the analysis.
The exclusion criteria were show as follows: secondary to system disease, baseline eGFR value of less than 15ml/min/1.732, biopsy age less than 18 years old, follow-up less than 6 months and lack of baseline BMI were excluded.
Table 1.
Baseline clinical variables of IgAN patients and analysis of those indicators affect ESRD by univariate Cox regression.
Fig 2.
Distribution of BMI in 930 IgAN patients.
(A) BMI goups were separated by age categories in all patients with IgAN, and then divided into males (B) and females(C).
Fig 3.
Kaplam-Meier Survival analysis of ESRD occurred in different BMI groups.
The mean ESRD-free time was 79.51±4.70, 89.90±1.55, 91.34±1.52 and 92.83±2.58 months for Underweight, Normal, Overweight and Obesity group, separately (p value = 0.03). Vertical tick lines indicate censor points.
Table 2.
Compare baseline data among different BMI groups categorized by WHO Asian standard.
Table 3.
Hazard ratios and 95% CI presented different progressive risk in four BMI groups.
Fig 4.
Correlation analysis assessed the relationship between any two indicators of BMI, serum C3, triglycerides and cholesterol.
(A) Correlation between serum C3 levels and BMI at baseline; (B) Correlation between the normal conversion of triglycerides and serum C3 levels; (C) Correlation between cholesterol and serum C3 levels; (D) Correlation between BMI and normal conversion of triglycerides; (E) Correlation between BMI and cholesterol.